Heerlen / NL. (dsm) Royal DSM N.V., a global science-based company active in health, nutrition and materials, announced preliminary results for Q1-2018, ahead of the scheduled Q1 results announcement on 08 May 2018. Highlights:
- Continued strong organic sales growth in underlying business estimated at 11 percent
- Adjusted Ebitda growth of underlying business estimated at 7 percent despite significant FX headwind
- Additional temporary vitamin price benefit estimated at 165 million EUR on Adjusted Ebitda
- Overall very strong quarter with total Adjusted Ebitda up 55 percent
CEO/Chairman Feike Sijbesma said: «We are very pleased that the strong underlying performance of our business continues, with growth well above market. In addition, we are currently benefiting from substantially higher prices in some vitamins due to exceptional supply disruptions in the industry, which are expected to be temporary and heavily weighted towards the first half of the year. These two combined result in a significantly higher outlook for the full year 2018».